Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalteparin for VTE Prophylaxis in Primary Care
NCT00655122Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Apr 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dalteparin in venous thromboembolism (VTE), sponsored by Pfizer. Started Apr 2003; status: terminated.
02
Drugs
dalteparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00655122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655122.